協成街何文田「芳菲」首推30伙 折實680萬元入場
協成行何文田勝利道5號住宅項目「芳菲」公布首張價單,涉30伙,包括14個一房及16個兩房單位,實用面積介乎286至465平方呎。價單售價由755.6萬至1,505.5萬元,呎價25,766元至32,376元。扣除最高10%折扣,折實售價680萬至1,355萬元,折實呎價23,188至29,140元。首批折實平均呎價26,139元,價單計市值約3億元。
協成行發展高級項目經理陳婉霞在記者會上表示,是次定價是參考九龍核心項目價格,預料項目將於本周六(24日)向公眾開放示範單位及收飛,最快下周公布銷售安排,會視乎市場反應再作未來部署。
對於有銀行暫停中國恆大(03333.HK)在港項目新造按揭,她稱集團有多年歷史,且與銀行有溝通,相信對集團影響不大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.